Opinion Article
Biosimilars in Dermatology: Starting With Infliximab
Biosimilares en dermatología: infliximab para empezar
L. Puig
Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Universidad Autónoma de Barcelona, Barcelona, Spain
Leído
11172
Vecesse ha leído el artículo
3517
Total PDF
7655
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 18 | 6 | 24 |
| 2025 5 | 138 | 45 | 183 |
| 2025 4 | 147 | 29 | 176 |
| 2025 3 | 135 | 22 | 157 |
| 2025 2 | 164 | 39 | 203 |
| 2025 1 | 107 | 27 | 134 |
| 2024 12 | 89 | 32 | 121 |
| 2024 11 | 110 | 54 | 164 |
| 2024 10 | 89 | 43 | 132 |
| 2024 9 | 83 | 27 | 110 |
| 2024 8 | 121 | 73 | 194 |
| 2024 7 | 93 | 28 | 121 |
| 2024 6 | 109 | 27 | 136 |
| 2024 5 | 104 | 36 | 140 |
| 2024 4 | 87 | 31 | 118 |
| 2024 3 | 70 | 32 | 102 |
| 2024 2 | 66 | 34 | 100 |
| 2024 1 | 64 | 36 | 100 |
| 2023 12 | 60 | 18 | 78 |
| 2023 11 | 61 | 23 | 84 |
| 2023 10 | 54 | 22 | 76 |
| 2023 9 | 43 | 29 | 72 |
| 2023 8 | 43 | 18 | 61 |
| 2023 7 | 53 | 32 | 85 |
| 2023 6 | 59 | 28 | 87 |
| 2023 5 | 52 | 23 | 75 |
| 2023 4 | 52 | 18 | 70 |
| 2023 3 | 60 | 28 | 88 |
| 2023 2 | 61 | 28 | 89 |
| 2022 1 | 61 | 30 | 91 |
| 2022 12 | 70 | 35 | 105 |
| 2022 11 | 71 | 19 | 90 |
| 2022 10 | 40 | 26 | 66 |
| 2022 9 | 62 | 38 | 100 |
| 2022 8 | 38 | 33 | 71 |
| 2022 7 | 34 | 32 | 66 |
| 2022 6 | 43 | 28 | 71 |
| 2022 5 | 35 | 37 | 72 |
| 2022 4 | 64 | 33 | 97 |
| 2022 3 | 58 | 48 | 106 |
| 2022 2 | 44 | 38 | 82 |
| 2021 1 | 52 | 32 | 84 |
| 2021 12 | 43 | 41 | 84 |
| 2021 11 | 65 | 46 | 111 |
| 2021 10 | 59 | 64 | 123 |
| 2021 9 | 56 | 52 | 108 |
| 2021 8 | 57 | 32 | 89 |
| 2021 7 | 43 | 44 | 87 |
| 2021 6 | 47 | 34 | 81 |
| 2021 5 | 72 | 36 | 108 |
| 2021 4 | 88 | 106 | 194 |
| 2021 3 | 49 | 32 | 81 |
| 2021 2 | 59 | 27 | 86 |
| 2020 1 | 45 | 29 | 74 |
| 2020 12 | 35 | 18 | 53 |
| 2020 11 | 21 | 20 | 41 |
| 2020 10 | 21 | 16 | 37 |
| 2020 9 | 44 | 13 | 57 |
| 2020 8 | 31 | 33 | 64 |
| 2020 7 | 21 | 24 | 45 |
| 2020 6 | 36 | 38 | 74 |
| 2020 5 | 27 | 17 | 44 |
| 2020 4 | 30 | 21 | 51 |
| 2020 3 | 40 | 19 | 59 |
| 2020 2 | 2 | 0 | 2 |
| 2020 1 | 0 | 5 | 5 |
| 2019 12 | 0 | 7 | 7 |
| 2019 9 | 0 | 2 | 2 |
| 2019 7 | 0 | 5 | 5 |
| 2019 6 | 0 | 8 | 8 |
| 2019 5 | 0 | 20 | 20 |
| 2019 4 | 0 | 22 | 22 |
| 2019 3 | 2 | 4 | 6 |
| 2019 2 | 3 | 5 | 8 |
| 2019 1 | 1 | 4 | 5 |
| 2018 12 | 4 | 4 | 8 |
| 2018 11 | 9 | 0 | 9 |
| 2018 10 | 7 | 0 | 7 |
| 2018 9 | 4 | 5 | 9 |
| 2018 8 | 0 | 11 | 11 |
| 2018 7 | 0 | 54 | 54 |
| 2018 6 | 0 | 34 | 34 |
| 2018 5 | 0 | 9 | 9 |
| 2018 3 | 4 | 1 | 5 |
| 2018 2 | 69 | 15 | 84 |
| 2018 1 | 61 | 37 | 98 |
| 2017 12 | 52 | 14 | 66 |
| 2017 11 | 58 | 23 | 81 |
| 2017 10 | 47 | 10 | 57 |
| 2017 9 | 62 | 21 | 83 |
| 2017 8 | 75 | 18 | 93 |
| 2017 7 | 61 | 19 | 80 |
| 2017 6 | 94 | 55 | 149 |
| 2017 5 | 91 | 34 | 125 |
| 2017 4 | 77 | 21 | 98 |
| 2017 3 | 61 | 22 | 83 |
| 2017 2 | 54 | 14 | 68 |
| 2016 1 | 54 | 18 | 72 |
| 2016 12 | 67 | 40 | 107 |
| 2016 11 | 165 | 23 | 188 |
| 2016 10 | 91 | 25 | 116 |
| 2016 9 | 146 | 78 | 224 |
| 2016 8 | 150 | 58 | 208 |
| 2016 7 | 112 | 44 | 156 |
| 2016 6 | 10 | 22 | 32 |
| 2016 5 | 4 | 36 | 40 |
| 2016 4 | 2 | 24 | 26 |
| 2016 3 | 4 | 26 | 30 |
| 2016 2 | 10 | 1 | 11 |
| 2015 1 | 8 | 3 | 11 |
| 2015 12 | 9 | 2 | 11 |
| 2015 11 | 5 | 16 | 21 |
| 2015 10 | 7 | 17 | 24 |
| 2015 9 | 12 | 1 | 13 |
| 2015 8 | 11 | 7 | 18 |
| 2015 7 | 92 | 133 | 225 |
| 2015 6 | 97 | 21 | 118 |
| 2015 5 | 108 | 36 | 144 |
| 2015 4 | 138 | 21 | 159 |
| 2015 3 | 91 | 5 | 96 |
| 2015 2 | 94 | 5 | 99 |
| 2015 1 | 92 | 6 | 98 |
| 2014 12 | 116 | 20 | 136 |
| 2014 11 | 138 | 10 | 148 |
| 2014 10 | 99 | 8 | 107 |
| 2014 9 | 77 | 7 | 84 |
| 2014 8 | 55 | 5 | 60 |
| 2014 7 | 48 | 7 | 55 |
| 2014 6 | 69 | 11 | 80 |
| 2014 5 | 68 | 13 | 81 |
| 2014 4 | 59 | 8 | 67 |
| 2014 3 | 73 | 23 | 96 |
| 2014 2 | 71 | 17 | 88 |
| 2014 1 | 57 | 14 | 71 |
| 2013 12 | 39 | 13 | 52 |
| 2013 11 | 48 | 12 | 60 |
| 2013 10 | 23 | 18 | 41 |
| 2013 9 | 22 | 13 | 35 |
| 2013 8 | 38 | 27 | 65 |
| 2013 7 | 11 | 11 | 22 |
| 2013 6 | 7 | 16 | 23 |
| 2013 5 | 3 | 9 | 12 |
| 2013 4 | 4 | 5 | 9 |
Mostrar todo
